Editas Medicine | 4:持股变动声明-高管 Mei Baisong
Editas Medicine | 4:持股变动声明-高管 O'Neill Gilmore Neil
Editas Medicine | 144:拟议出售证券
Editas Medicine | 144:拟议出售证券
Editas Medicine | 10-Q:2024财年二季报
Editas Medicine | 8-K:Editas Medicine 公布2024年第二季度业绩和业务更新
Editas Medicine | 4:持股变动声明-高管 Burkly Linda
Editas Medicine | 4:持股变动声明-高管 Mei Baisong
Editas Medicine | 144:拟议出售证券
Editas Medicine | 144:拟议出售证券
Editas Medicine | SC 13G/A:超过5%持股股东披露文件(修正)-STATE STREET CORPORATION(5.58%)
Editas Medicine | 8-K:重大事件
Editas Medicine | 8-K:重大事件
Editas Medicine | 4:持股变动声明-高管 O'Neill Gilmore Neil
Editas Medicine | 4:持股变动声明-高管 Mei Baisong
Editas Medicine | 4:持股变动声明-董事 Scadden David
Editas Medicine | 4:持股变动声明-董事 Chatterjee Meeta
Editas Medicine | 4:持股变动声明-董事 Hopfield Jessica
Editas Medicine | 4:持股变动声明-董事 Hirsch Andrew
Editas Medicine | 4:持股变动声明-董事 Connaughton Bernadette
暂无数据
暂无数据